INTRODUCTION
Both in vivo [1] and in vitro [2] [3] [4] experiments demonstrated that bovine interferon-tau (bIFN-) is able to attenuate endometrial production of prostaglandin F 2␣ (PGF 2␣ ). A variety of experimental models have been used to demonstrate this effect of bIFN-, including explants [2] and primary cultures of endometrial epithelial cells collected on Days 1 to 4 [4] or 15 of the estrous cycle [3] . The aforementioned approaches involve synchronization and slaughter of animals at specific stages of the estrous cycle or collecting reproductive tracts from commercial slaughter facilities in order to obtain cells to conduct experiments. These approaches are both time and resource consuming. Moreover, production of PGF 2␣ is highly variable among animals, which makes interpretation of results challenging. An alternative experimental model for studying effects of bIFN-in the endometrium is use of bovine endometrial (BEND) cells. BEND cells are a line of spontaneously replicating epithelial cells originating from Day 14 cyclic cows [5] . The overall goal of this study was to characterize the effect of bIFN-on production of PGF 2␣ from BEND cells, and the working hypothesis was that bIFN-has an inhibitory effect on stimulated synthesis of PGF 2␣ .
Oxytocin stimulates production of PGF 2␣ from primary endometrial epithelial cells in culture [3, 4] . Oxytocin binds to a seven-transmembrane domain and to G protein-coupled receptors and activates phospholipase C (PLC). The PLC cleaves membrane phosphatidylinositol bisphosphate, yielding inositol triphosphate (IP 3 ) and diacylglycerol (DAG). The IP 3 binds to specific receptors in the endoplasmic reticulum, resulting in release of calcium from internal stores into the cytosolic compartment. The DAG activates protein kinase C (PKC), leading to serine phosphorylation of cytosolic, calcium-dependent phospholipase A 2 (PLA 2 ) through a MAP kinase-dependent pathway [6] . The IP 3 -induced increase in cytosolic calcium acts to further stimulate PLA 2 activity [7] . Stimulated PLA 2 translocates to the membrane, where phospholipids are cleaved to yield arachidonic acid (AA; [7] ). Free AA is converted to prostaglandin H 2 (PGH 2 ) by the enzyme cyclooxygenase-2 (COX-2). Prostaglandin F 2␣ synthase converts PGH 2 into PGF 2␣ , which is then released into the uterine vein [8] .
In a preliminary experiment (unpublished results) it was determined that 1-h treatment with oxytocin failed to stimulate production of PGF 2␣ from BEND cells. Furthermore, Arnold and coauthors [9] demonstrated that treatment of Day 15 endometrial explants with phorbol 12,13 dibutyrate (PDBu; an stimulator of PKC activity), but not oxytocin, induced production of PGF 2␣ . Using endometrial cells collected on Days 1 to 4 of the estrous cycle, Xiao and coworkers [4] determined that phorbol 12-myristate 13-acetate (PMA) increased both production of PGF 2␣ and expression of COX-2 protein. In addition, these authors reported that bIFN-reduced both of these PMA-induced effects. Objectives of the present study were to 1) test whether PDBu could stimulate PGF 2␣ production from BEND cells and whether bIFN-could block such an effect, 2) study the time-response dynamics of PDBu-induced PGF 2␣ production in the presence or absence of bIFN-, and FIG. 1. Total PGF 2␣ in medium from BEND cells treated with medium alone (Con), bIFN-(50 ng/ml; IFN), phorbol 12,13 dibutyrate (100 ng/ ml; PDBu) or bIFN-and PDBu. a) Experiment 1. Samples were removed before treatments were added (0 h), 12 and 24 h after. b) Experiment 2. Samples were removed before treatments were added (0 h), 3, 6, 9, and 12 h after. c) Experiment 3. Samples were removed before treatments were added (0 h), 1, 2, 3, 4, 5 and 6 h after. Details of statistical differences are described in Results.
3) examine the effects of PDBu on steady-state levels of COX-2 mRNA and on PLA 2 and COX-2 protein expression in the presence or absence of bIFN-. 
MATERIALS AND METHODS

Materials
Cell Culture and Experimental Designs
Isolation of BEND cells from a primary cell culture is described by Staggs et al. [5] . The cell line is deposited and characterized by the American Type Culture Collection (ATCC number CRL-2398; ATCC, 10801 University Boulevard, Manassas, VA 20110-2209). The ATCC describes methodology for subculturing, propagation, and freezing and for products produced by the cells. BEND cells were plated on 100-mm tissue culture dishes (8.5 ϫ 10 5 cells per plate) in culture medium (40% Ham F-12, 40% MEM, 10 ml AbAm/L, 200 U insulin/L, 0.0343g D-valine/L, 10% fetal bovine serum, and 10% horse serum) for experiments 1, 2, 3, and 4 or on 35-mm wells on six-well plates (2 ϫ 10 5 cells per well) for experiment 5. Cells were grown to confluency at 37ЊC under a humidified atmosphere containing 95% O 2 and 5% CO 2 , washed in serum-free medium, and cultured for an additional 24 h in serum-free medium. After this time (designated as 0 h), a sample of medium was collected and stored at Ϫ20ЊC (experiments 1, 2, and 5). Then cells were washed again, and serum-free medium was mixed with appropriate treatments and added to cells in the same volumes listed above. Samples of medium (500 l in experiments 1, 2, and 3; 250 l in experiment 5) were collected at specified times and stored at Ϫ20ЊC. After sampling, the same volume of medium removed was replaced with medium containing the appropriate treatment so that a constant volume was maintained throughout each experiment. Concentrations of PGF 2␣ were measured in medium as described below. Experiment 1. Cultures (20 ml of culture medium, n ϭ 8) were assigned randomly to receive bIFN-(0 or 50 ng/ ml) or PDBu (0 or 100 ng/ml) in duplicate, in a 2 ϫ 2 FIG. 2. Experiment 5. Least-squares means and SEM of concentrations of PGF 2␣ in medium conditioned by BEND cells treated with medium alone (Con), phorbol 12,13 dibutyrate (100 ng/ml; PDBu), PDBu and bIFN-(50 ng/ml; IFN) added concomitantly, and PDBu for 3 h followed by PDBu and bIFN-(see text). Samples were removed before treatments were added (0 h), 1, 2, 3, 4, 5, and 6 h after. Details of statistical differences are described in Results.
factorial design, for 24 h. Medium was sampled after 12 and 24 h of treatment. After the 24-h sample, remaining medium was discarded and cells harvested for extraction of proteins.
Experiment 2. Cultures (10 ml of culture medium, n ϭ 10) were assigned randomly to receive medium alone (control, three plates), PDBu (100 ng/ml, four plates) or PDBu in combination with bIFN-(50 ng/ml, four plates) for 12 h. Medium was sampled after 3, 6, 9, and 12 h of treatment. After collection of 12-h samples, remaining medium was discarded and cells were harvested for extraction of proteins.
Experiment 3. Cultures (10 ml of culture medium, n ϭ 27) were assigned randomly to receive medium alone (control, nine plates), PDBu (100 ng/ml, nine plates), or PDBu in combination with bIFN-(50 ng/ml, nine plates). Medium was sampled after 1, 2, 3, 4, 5, and 6 h of treatment. After collecting the 6-h sample, three plates per treatment were used for protein extracts. Cells on additional plates were harvested for RNA extraction after 3 h (three plates per treatment) or 6 h (three plates per treatment).
Experiment 4. Cultures (10 ml of culture medium, n ϭ 16) were assigned randomly to receive medium alone (control, four plates), PDBu (100 ng/ml, six plates), or PDBu in combination with bIFN-(50 ng/ml, six plates). Wholecell extracts (WCE) were prepared from control cultures (0 h; four plates) and from treated plates after 6, 12, and 24 h of exposure to treatments (two plates per treatment per time) and used for immunoblots.
Experiment 5. Cultures (3 ml of culture medium, n ϭ 12) were assigned in triplicate to receive medium alone (control), PDBu (100 ng/ml), PDBu in combination with bIFN-(50 ng/ml), or PDBu for 3 h and PDBu in combination with bIFN-for an additional 3 h. Medium was sampled after 1, 2, 3, 4, 5, and 6 h of treatment. This experiment was replicated once.
Preparation of Cell Extracts and Immunoblotting Analysis
At the end of culture periods, plates were transported to a cold room (4ЊC), culture medium was discarded, and cells were rinsed twice in ice-cold PBS containing 1 mM Na 3 VO 4 and 5 mM NaF. Cells were washed briefly in 1 ml of WCE buffer (50 mM Tris, pH 8.0, 300 mM NaCl, 20 mM NaF, 1 mM Na 3 VO 4 , 1 mM Na 4 P 2 O 7 , 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol (DTT), 0.5 mM PMSF, 10% v/v glycerol, 0.5% v/v NP-40, and 10 g/ml each of aprotinin, leupeptin, and pepstatin) and allowed to drip dry. Cells were scraped from plates in the presence of 1 ml of WCE buffer, incubated on ice for 10 min, and disrupted by aspiration through a 25-gauge needle. Lysates were then processed by centrifuge (13 000 ϫ g for 2 min), and protein concentrations were determined in supernatants by the Bradford method [10] . Protein (20 g) from each plate was loaded onto duplicate 7.5% acrylamide gels, submitted to SDS-PAGE, and electrophoretically transferred to nitrocellulose membranes. Membranes were blocked for 2 h in 5% (w/v) nonfat dried milk in Tris-buffered saline (TBS) containing 0.1% Tween-20 (TBST), washed for 15 min in TBST and separately probed with antibodies against either COX-2 (1:1000) or PLA 2 (1:250) diluted in 5% nonfat dried milk in TBS. Secondary antibody was anti-rabbit IgG (1:5000 dilution in 5% nonfat dried milk in TBST). Proteins were detected by ECL and analyzed by densitometry (AlphaImager 2000; Alpha Innotech Corporation, San Leandro, CA).
RNA Isolation and Northern Blot Analysis
To obtain RNA (experiment 3), plates were transported to a cold room (4ЊC) and washed twice with ice-cold PBS; total RNA was isolated from confluent BEND cells with Trizol according to the manufacturer's specifications. Total cellular RNA (30 g per lane) was fractionated in a 1.5% agarose-formaldehyde gel, stained with ethidium bromide, blotted to BioTrans nylon membrane, and hybridized with a homologous bovine COX-2 cDNA probe. The bovine COX-2 cDNA was cloned from an ovarian follicular cDNA library (unpublished data; GenBank accession number AF031698), and its sequence was shown to be identical to that of the corresponding exonic sequences of the bovine COX-2 gene [11] . The probe was labeled by nick translation as described elsewhere [12] . The COX-2 mRNA transcript was identified by autoradiography and hybridization
Immunoblotting analysis of COX-2 and PLA 2 in whole-cell extracts from BEND cells treated with phorbol 12,13 dibutyrate (100 ng/ml; PDBu) or bIFN-(50 ng/ml; IFN) and PDBu for 0, 6, 12, or 24 h. a) Representative-enhanced ECL exposure of abundance of total COX-2 and least-squares means (ϮSEM) of abundance of total COX-2 arbitrary densitometric units (ADU). b) Representative ECL exposure of abundance of total PLA 2 and least-squares means (Ϯ SEM) of abundance of total PLA 2 ADU. Details of statistical differences are described in Results. ** Differences between means within time significant at P Ͻ 0.01. signals analyzed by densitometry. To normalize loading of samples, 28s ribosomal RNA was also quantified, and densitometric values were used as a covariate in the analysis of variance.
Radioimmunoassay
Concentrations of PGF 2␣ were measured in medium undiluted (control-, bIFN--and PDBu ϩ bIFN--treated cells) or diluted 1:2 in medium (PDBu-treated cells) as described by Danet-Desnoyers and coworkers [3] . Assay was validated for serum-free medium by adding 25 pg/0.1 ml PGF 2␣ to medium. Average recovered PGF 2␣ was 25.1 Ϯ 1.42 pg/0.1 ml (100.25%). Anti-PGF 2␣ antiserum utilized was characterized by Dubois and Bazer [13] and diluted 1: 5000 (Tris buffer). Minimum detectable concentration of PGF 2␣ was 3.32 pg per tube. Inter-and intraassay coefficients of variation were 13.99 and 12.61%, respectively. Because multiple samples were removed and medium was added back to plates, concentrations of PGF 2␣ were adjusted to account for PGF 2␣ removed from previous samples. Adjustment consisted of adding the amount of PGF 2␣ removed in previous samples to the amount measured in the current sample. Total cell protein was determined, and total PGF 2␣ values per well were expressed as micrograms of protein.
Statistical Analysis
Data were analyzed by least-squares analysis of variance, using the GLM procedure from SAS [14] . Data for each experiment were analyzed separately. The PGF 2␣ data were analyzed as a split-plot design. For experiments 1, 2, and 3, independent variables in the mathematical models were as follows: treatment, dish (or well) within treatment, time, treatment ϫ time, and residual error. The term dishwithin-treatment was the error term for effects of treatment. For experiment 5, independent variables in the mathematical models were as follows: experiment, treatment, experiment ϫ treatment, well within experiment ϫ treatment, time, experiment ϫ time, treatment ϫ time, and residual error. The term well within experiment by treatment was the error term for the effects of treatment and experiment. Heterogeneity of variance among treatments was tested by the maximum F-ratio test (F max ; [15] ) and found significant in all experiments. Therefore, data were transformed to log 10 and retested for heterogeneity of variance. Transformations effectively eliminated heterogeneity of variance for experiments 2, 3, and 5 but not for experiment 1. In experiment 1, the Box-Cox procedure for data transformation was applied [16] , and a value of 0.4 was found to eliminate heterogeneity of variance. Data were analyzed after appropriate transformations. However, for the sake of clarity, data are presented as untransformed values. Means were compared as a series of preplanned orthogonal contrasts of treatment, time, and treatment by time.
Prostaglandin-F 2␣ production data were further analyzed by homogeneity of regression to determine regression equations for each treatment within experiments and to perform orthogonal comparisons of PGF 2␣ production among treatments.
For abundance of COX-2 and PLA 2 , the mathematical model included the effects of treatment, time, and treatment by time (Northern blots in experiment 3 and immunoblots in experiment 4). Abundance of mRNA for Northern blots of COX-2 in experiment 3 was adjusted for 28s RNA as a covariate. Orthogonal contrasts were used for mean comparisons.
RESULTS
Effects of PDBu and bIFN-on PGF 2␣ Production
Production of PGF 2␣ at time 0 was low (Ͻ0.3 pg per microgram protein) for all treatments (Fig. 1, a and b; Fig.  2 ). Accumulation of PGF 2␣ for the control group was negligible in all experiments ( Figs. 1 and 2 ; P Ͻ 0.01). Similarly, incubations with bIFN-alone had no effect on PGF 2␣ production (Fig. 1, panel a) . Treatment of BEND cells with PDBu induced production of PGF 2␣ compared with the case Northern blotting analysis of COX-2 mRNA in total RNA extracts from BEND cells treated with medium alone (Con), phorbol 12,13 dibutyrate (100 ng/ml; PDBu), or bIFN-(50 ng/ml; IFN) and PDBu for 3 or 6 h. a) Autoradiography exposure of abundance of COX-2 mRNA. b) Ethidium bromide staining of 28S ribosomal RNA. c) Least-squares means and SEM of abundance of COX-2 mRNA arbitrary densitometric units. Details of statistical differences described in Results. PDBu stimulated (** P Ͻ 0.01) abundance of COX-2 mRNA, which was blocked by IFN at both 3 and 6 h.
FIG. 5. Hypothetical model of actions of bovine interferon-tau (bIFN-)
to prevent protein kinase C (PKC)-induced production of PGF 2␣ in endometrial epithelial cells. Activation of PKC stimulates synthesis (white squares) and enzymatic activity (gray diamonds) of specific endometrial proteins, such as phospholipase A 2 (PLA 2 ) and cyclooxygenase-2 (COX-2) to ultimately stimulate synthesis of PGF 2␣ . PKC may stimulate synthesis or activity of other cellular mediators, such as kinases, lipases, and transcription factors to further enhance synthesis and activity of enzymes directly involved in the PGF 2␣ production. Binding of bIFN-to the type I receptor, here represented with a hypothetical, bIFN--specific chain (R), may have protein synthesis-dependent (through activation of the JAK-STAT pathway; right side of diagram) or -independent (left side of diagram) actions to decrease production of PGF 2␣ . STAT dimers may translocate to the nucleus to stimulate transcription of interferon-inducible genes and to repress transcription of genes related to synthesis of PGF 2␣ . The bIFN--induced proteins (crossed circles) may act as transcription factors to regulate transcription of genes, or may have cytosolic actions to regulate activity of enzymes involved in production of PGF 2␣ . Alternatively, bIFNmay regulate activity of preexisting cellular mediators (black circles) to negatively affect the PGF 2␣ synthesizing machinery.
of controls ( Figs. 1 and 2 ; P Ͻ 0.01). Initial stimulation by PDBu was detected after 2 h of exposure (Fig. 1c) , and increased at a rate of 47.4 pg per microgram of protein per 6 h between 0 and 6 h (Fig. 1b) . A further increase in PGF 2␣ production was detected but occurred at a lower rate between 6 and 12 h (14.7 pg per microgram of protein per 6 h; Fig. 1b) , but no more accumulation occurred after 12 h of exposure to PDBu (Fig. 1a) . Incubations with bIFNattenuated the PDBu-induced production of PGF 2␣ at all time points studied ( Figs. 1 and 2 ; treatment ϫ time interaction, P Ͻ 0.01). Furthermore, analysis of homogeneity of regression confirmed changes in production rates of PGF 2␣ during the experiments. Equations for each experiment were calculated (data not shown), and fit of regression curves were R 2 ϭ 0.968 (P Ͻ 0.01), R 2 ϭ 0.982 (P Ͻ 0.01), and R 2 ϭ 0.954 (P Ͻ 0.01) for experiments 2, 3, and 5, respectively. Orthogonal comparisons of curves confirmed that PDBu stimulated PGF 2␣ production and that bIFN-reduced that effect (P Ͻ 0.01). The fact that inhibitory effects of bIFN-on PDBu-induced PGF 2␣ production were noted as early as 2 h (time when first PDBu-induced rise in PGF 2␣ is noted; experiment 3; Fig. 1c ) prompted us to examine how quickly bIFN-would be able to suppress synthesis of PGF 2␣ in cells exposed previously to PDBu. We chose to add bIFN-after 3-h exposure to PDBu because 1) PDBu-induced PGF 2␣ production was increasing at a fast rate by this time (Fig. 1, b and c) , which indicates that the PGF 2␣ -synthesizing machinery was present and functional and 2) maximum production rate was noticed in the first 6 h of PDBu stimulation (experiment 2; Fig. 1b) . In experiment 5, addition of bIFN-after a 3-h exposure to PDBu caused a decrease in PDBu-induced PGF 2␣ production, which was noticeable at the 5-h sample and became even more pronounced at the 6-h sample (Fig. 2) . More-over, rate of accumulation of PGF 2␣ in the medium between 4 and 6 h was greater in absence of bIFN-(1201 pg per milliliter per 2 h for PDBu vs. 442 pg per milliliter per 2 h for PDBu ϩ bIFN--3h). Furthermore, when PDBu and PDBu ϩ bIFN--3h treatments were analyzed without other treatments, there was a time ϫ treatment interaction (P Ͻ 0.01), indicating that bIFN-effectively suppressed PDBustimulated PGF 2␣ production, even when added after PDBu treatment had been initiated. Orthogonal comparison of curves representing production of PGF 2␣ induced by PDBu and by PDBu ϩ bIFN--3h indicated a treatment effect (P Ͻ 0.01).
Effects of PDBu and bIFN-on COX-2 and PLA 2 Protein Expression: COX-2 and PLA 2 Immunoblotting
There was a low abundance of COX-2 and PLA 2 in cells incubated with medium alone or with bIFN-in experiments 1 to 3 (data not shown) and 4 (Fig. 3) . However, treatment with PDBu increased synthesis of both COX-2 (P Ͻ 0.01) and PLA 2 (P Ͻ 0.1; experiment 4). The PDBu induced a sharp increase in the abundance of COX-2 to reach maximum levels by 6 h of treatment, compared to controls (Fig. 3a) . The abundance of COX-2 remained elevated at 12 h but decreased by 24 h. PBDu stimulated an increase in the abundance of PLA 2 to reach a maximum at 12 h but decreased by 24 h (effect of time; P Ͻ 0.02; Fig.  3b) . In experiment 4, presence of bIFN-reduced the PDBu-induced increase in COX-2 (experiment 4; Fig. 3a ; treatment effect; P Ͻ 0.01). However, the ability of bIFNto suppress the PDBu-stimulated COX-2 tended to decrease over time (treatment ϫ time interaction; P Ͻ 0.09). Presence of bIFN-tended to attenuate the PDBu stimulation of PLA 2 (effect of treatment; P Ͻ 0.1). Most of the difference in abundance of PLA 2 between treatments was noted between 12 and 24 h.
Effects of PDBu and bIFN-on Steady-State Levels of COX-2 mRNA: COX-2 Northern Blotting
There was an effect of treatment on the abundance of COX-2 mRNA (P Ͻ 0.01, Fig. 4a ). In the absence of bIFN-, PDBu increased steady-state levels of the COX-2 mRNA compared with controls. However, this effect was attenuated when cells were incubated with a combination of bIFN-and PDBu. Similar responses were observed both after 3 or 6 h of exposure to treatments (treatment by time interaction, P Ͼ 0.1). A similar abundance of 28S ribosomal RNA indicated that a similar amount of RNA was loaded per lane (Fig. 4b) .
DISCUSSION
BEND cells provide a model for studying regulation of PGF 2␣ in the endometrium. Previous studies utilized endometrial epithelial cells in primary culture harvested from uteri collected from Day 15 [3] or from Days 1-4 cyclic cows [4, 17, 18] , but collection procedures are time and resource consuming. BEND cells can be used repeatedly for at least 25 passages and still maintain phenotype (unpublished observations). Moreover, BEND cells originated from Day 14 cyclic cows, which provided endometrial cells that were primed, in vivo, with progesterone. This stage of the estrous cycle is appropriate to study mechanisms of bIFN-action in suppressing release of PGF 2␣ . Using BEND cells, it was determined that bIFN-suppresses PGF 2␣ probably through inhibiting steady-state levels of COX-2 mRNA, protein expression and enzymatic activity of COX-2 and PLA 2 . Moreover, bIFN-suppression of PDBu-induced PGF 2␣ production was achieved within 2 h.
Phorbol esters such as PMA stimulate PGF 2␣ production in vitro [4] . In the present study, PDBu increased PGF 2␣ production for 12 h but failed to maintain induction from 12 to 24 h of culture. The loss of action of PDBu after 12 h may have been because of depletion of AA (precursor for PGF 2␣ synthesis) or down-regulation of the PKC pathway in response to long-term stimulation by PDBu. The PDBu induced maximum production of PGF 2␣ during the first 6 h, followed by a decrease between 6 and 12 h. The induction of PGF 2␣ required a 2-h period. This suggests that PDBu activity is, at least initially, dependent on de novo protein synthesis and not on stimulation of activity of preexisting enzymes involved in PGF 2␣ production. Nam and others [19] , reported that the protein synthesis inhibitors actinomycin D and cycloheximide blocked the ability of PDBu to stimulate PGF 2␣ production in astroglial cells.
When added alone to BEND cells, bIFN-had no effect on PGF 2␣ production. Thus, treatment with bIFN-alone was excluded from subsequent experiments. In contrast, bIFN-effectively suppressed the PDBu-induced production of PGF 2␣ in all experiments. However, bIFN-was never able to completely suppress PDBu-stimulated PGF 2␣ . Perhaps other products of the conceptus are required to abolish PGF 2␣ completely in vivo. These findings confirm and expand those of Xiao and coworkers [4] . However, attenuation of PGF 2␣ by bIFN-in the present study was much more dramatic.
Treatment with PDBu strongly induced synthesis of both COX-2 and PLA 2 protein compared with the case of controls. This was detected as early as 6 h and lasted for at least 12 h. PDBu-stimulated COX-2 expression was also related to an increased expression of the COX-2 gene, which was elevated as early as 3 h and remained high for at least 6 h (experiment 3). Increased abundances of COX-2 and PLA 2 probably were related to their increased cellular activity, as evaluated through increased PGF 2␣ accumulation in medium. Presence of bIFN-reduced PDBu-stimulated PLA 2 and COX-2 protein expression, but such effects were time dependent. Responses of PLA 2 were somewhat variable but were consistently lower than PDBu treatment alone. When related to time trends of PGF 2␣ production, results from experiment 4 suggest that maximum protein levels of COX-2 (6 to 12 h) were related to maximum production of PGF 2␣ . Moreover, the decrease in COX-2 protein noted at 24 h corresponded to a cessation in the production of PGF 2␣ , probably because of down-regulation of the PKC system [20, 21] . In contrast, bIFN-delayed both the increased expression of COX-2 and the accumulation of PGF 2␣ induced by PDBu. Presence of bIFN-may have inhibited, but did not abolish, the PDBu-stimulated PKC pathway. As a consequence, there was an increasing accumulation of PGF 2␣ over time, and this may be due to an inhibition of the PDBu down-regulation of the PKC system by bIFN-. Thereby, similar levels of COX-2 noted at 24 h represented different levels of PGF 2␣ secretory activity (i.e., cessation in PDBu-treated cells but increase in PDBuϩbIFN--treated cells). Altogether, these observations are consistent with those of Xiao and others [4] , who reported that PMA increased COX-2 protein expression (about fivefold higher than that of controls) and that bIFNattenuated that response (to about 2.5-fold higher than that of controls). Presence of bIFN-reduced all responses measured at all time points. In contrast, Asselin et al. and others [17] reported no changes in PLA 2 gene expression after treatment of endometrial and stromal cells with bIFN-. Moreover, COX-2 expression was up-regulated by bIFN-. Large doses of bIFN-(1 to 20 g/ml [17] vs. 50 ng/ml in the current study) could explain this discrepancy of results. Collectively, our results suggest that bIFN-exerts a complex regulation of both PLA 2 and COX-2 gene expression and activity to modulate PGF 2␣ production in BEND cells. The upstream regulator of both PLA 2 and COX-2 is PKC. Phorbol esters mimic the action of diacylglycerol, a product of PLC activity, which has the effect of activating PKC activity. The PKC may stimulate PGF 2␣ production via stimulation of synthesis and/or activity of both PLA 2 [22, 23] and COX-2 [24, 25] . Therefore, effects of bIFNcould be at the level of PKC to inhibit the ability of this enzyme to stimulate PGF 2␣ synthesis through modulation of its mediators, PLA 2 and COX-2. Because not all PDBuinduced PKC effects were suppressed (i.e., there was still PGF 2␣ production, even in presence of bIFN-), it is unlikely that bIFN-effects were exerted upstream from PKC (e.g., a block on PDBu ability to bind PKC). It is likely that bIFN-blocked some, but not all, PDBu effects downstream from PKC.
Decreased rate of production of PGF 2␣ at 2 h after addition of bIFN-(PDBu ϩ bIFN--3 h treatment, experiment 5) indicated that bIFN-was able to quickly suppress PDBu-induced PGF 2␣ . The exact mechanism whereby bIFN-exerted its effects is unknown; however, it is tempting to speculate that such a quick action is independent of protein synthesis and can occur through novel, previously undescribed cytosolic (i.e., nuclear independent) actions of bIFN-.
The observation that attenuation of PGF 2␣ synthesis occurred within 2 h is consistent with activation of the janus kinase (JAK) signal transducers and activators of transcription (STAT) pathway [26] [27] [28] but also suggests that bIFNmay act through additional pathways (Fig. 5) . The JAK-STAT pathway involves phosphorylation and nuclear translocation of cytoplasmic STAT proteins, as a result of bIFNbinding to its receptor [26] [27] [28] . In the nucleus, STAT proteins act as transcription factors to stimulate expression of interferon-stimulated genes. Interferon-induced proteins may act in a variety of ways to produce the interferoninduced phenotype. Presence and function of this classical mode of action in the endometrium has been the prevalent dogma of laboratories studying effects of bIFN-on production of PGF 2␣ during maternal recognition of pregnancy in cattle and sheep [31] . For example, interferonstimulated gene 17 (ISG17; a ubiquitin cross-reactive protein) is induced by bIFN-in endometrial explant culture [5, 32] . This protein forms complexes with other cytosolic proteins and could modulate their activity and turnover rate [32] . In BEND cells, complex formation requires 3 h of exposure to bIFN-(unpublished observations), which makes ISG17 a possible mediator of early bIFN-suppression of PGF 2␣ . Other possible mediators of bIFN-actions include the interferon-induced transcription factors IRF-1 and IRF-2 [31, 33] . IRFs are rapidly synthesized in response to bIFN- [28] and could induce synthesis of specific proteins to suppress PGF 2␣ synthesis. However, it is possible that a protein synthesis-independent mode of action for bIFN-operates in the endometrium to suppress PGF 2␣ production. Bovine IFN-could activate intracellular second messengers other than STAT proteins, which may have modulatory effects on the PGF 2␣ synthesizing machinery. Critical studies to dissect such alternative pathways induced by bIFN-warrant investigation.
